Status:

RECRUITING

AdventHealth Research Institute Non-Alcoholic Fatty Liver Disease Biobank and Registry (AVAIL)

Lead Sponsor:

AdventHealth Translational Research Institute

Collaborating Sponsors:

BPGbio

Conditions:

Non-Alcoholic Fatty Liver Disease

Eligibility:

All Genders

18+ years

Brief Summary

The purpose of this study is to create a resource that will advance research that is focused on discovery of novel therapies, risk stratification, and aggressive interventions for those at highest ris...

Eligibility Criteria

Inclusion

  • Inclusion Criteria
  • Females and Males ≥ 18 years of age.
  • Understands the procedures and agrees to participate by giving written informed consent.
  • Biopsy Group Only:
  • • Scheduled for standard of care liver biopsy for any reason.
  • Non-Biopsy Group Only:
  • • BMI ≥ 25, with or without type 2 diabetes, without any level of NAFLD based on: (1) Recent medical history (within 6 months of screening visit). (2) Data collected from participation in a prior research study where they consented to be re-contacted for future studies.
  • Exclusion Criteria
  • Women who are pregnant when referred for a liver biopsy will be excluded.
  • Presence of any condition that, in the opinion of the Investigator, compromises participant safety or data integrity or the participant's ability to complete the study.
  • Otherwise, all eligible patients who consent will be included in AVAIL. If participants in the non-biopsy group are found to have NAFLD based on the FibroScan done for this study, then they will be informed of this and advised to follow up with their physician. Their data will still be part of the registry and analyzed with the biopsy group that is found to have NAFLD.

Exclusion

    Key Trial Info

    Start Date :

    April 22 2021

    Trial Type :

    OBSERVATIONAL

    Allocation :

    ESTIMATED

    End Date :

    March 1 2026

    Estimated Enrollment :

    1250 Patients enrolled

    Trial Details

    Trial ID

    NCT04807868

    Start Date

    April 22 2021

    End Date

    March 1 2026

    Last Update

    March 13 2025

    Active Locations (1)

    Enter a location and click search to find clinical trials sorted by distance.

    Page 1 of 1 (1 locations)

    1

    AdventHealth Translational Research Institute

    Orlando, Florida, United States, 32804